SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-098957
Filing Date
2023-09-07
Accepted
2023-09-07 16:23:28
Documents
2
Period of Report
2023-09-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2325621-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2325621-1_3seq1.xml 3 6721
2 EXHIBIT 24.1 tm2325621d1_ex24-1.htm EX-24.1 8951
  Complete submission text file 0001104659-23-098957.txt   17024
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Issuer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XILIO THERAPEUTICS, INC. 828 WINTER STREET WALTHAM MA 02451
Business Address
Luptakova Katarina (Reporting) CIK: 0001991149 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40925 | Film No.: 231242557